Hinge Health, Inc. (NYSE: HNGE) reported second-quarter 2026 revenue of $212.8 million, a 53% increase from $139.1 million in the same period a year earlier, according to a company press release.

The digital health company also announced a definitive agreement to acquire Cylinder Health, Inc., a virtual digestive healthcare company, for $105 million in cash. The deal is expected to close in the third quarter of 2026, subject to customary closing conditions. An integrated gastrointestinal care program is expected to launch in 2027.

Free cash flow for the quarter reached $99.6 million, compared with $32.6 million in the second quarter of 2025. Net cash from operating activities rose to $101.4 million from $20.2 million a year earlier.

On a GAAP basis, income from operations was $40.4 million, compared to a loss of $580.7 million in Q2 2025, which included $591 million in stock-based compensation expense. Non-GAAP income from operations increased 136% year-over-year to $61.5 million. GAAP diluted net income per share was $0.52, versus a loss of $13.10 in Q2 2025. Non-GAAP diluted net income per share was $0.59, up from $0.30.

The company's client count rose 24% year-over-year to 2,929 as of June 30, 2026. Cash, cash equivalents, marketable securities, and restricted cash totaled $475.6 million at quarter-end.

Hinge Health raised its full-year 2026 revenue guidance to a range of $856 million to $860 million, reflecting 46% year-over-year growth at the midpoint. Full-year non-GAAP income from operations guidance was raised to a range of $236 million to $244 million.

For the third quarter of 2026, the company expects revenue between $223 million and $225 million and non-GAAP income from operations between $61 million and $63 million.

The board of directors approved a $300 million increase to the company's existing share repurchase program. As of July 29, 2026, the company had repurchased $196.5 million of Class A common stock under the original $250 million authorization, leaving a total of $300 million available for future repurchase under the expanded program.